Literature DB >> 18952289

IL-10 suppresses CD2-mediated T cell activation via SHP-1.

Alison Taylor1, Johan Verhagen, Tunç Akkoç, Renate Wenig, Egbert Flory, Kurt Blaser, Mübeccel Akdis, Cezmi A Akdis.   

Abstract

Interleukin (IL)-10 is an essential suppressive cytokine and plays a key role in peripheral T cell tolerance to allergens, autoantigens, transplantation antigens and tumor antigens. However, the molecular mechanisms of direct T cell suppression by IL-10 are not fully understood. Here, we demonstrate that IL-10 directly inhibits CD2 signaling in T cells. T cell stimulation via CD2 alone induces activation and proliferation, when endogenous IL-10 sources are eliminated from cultures. IL-10 utilizes the src-homology-2 domain containing tyrosine phosphatase (SHP-1) to directly suppress T cell activation. The role of SHP-1 in IL-10-mediated suppression of CD2 co-stimulation on T cells is demonstrated by using dominant-negative SHP-1 over-expressing T cells and silencing endogenous SHP-1 by small inhibitory RNA. Findings are confirmed using both SHP-1-deficient mice and IL-10-deficient mice. CD2-induced proliferation is suppressed by exogenous IL-10 in IL-10-deficient, but not SHP-1-deficient murine T cells. In conclusion, SHP-1-mediated inhibition of CD2 signaling represents a novel mechanism for direct T cell suppression by IL-10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952289     DOI: 10.1016/j.molimm.2008.07.031

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Authors:  Matthias T Stephan; Sirkka B Stephan; Peter Bak; Jianzhu Chen; Darrell J Irvine
Journal:  Biomaterials       Date:  2012-05-15       Impact factor: 12.479

Review 3.  Current status of interleukin-10 and regulatory T-cells in cancer.

Authors:  Kristen L Dennis; Nichole R Blatner; Fotini Gounari; Khashayarsha Khazaie
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

Review 4.  The role of costimulatory molecules in allergic disease and asthma.

Authors:  Vincent Lombardi; Abinav K Singh; Omid Akbari
Journal:  Int Arch Allergy Immunol       Date:  2009-09-29       Impact factor: 2.749

5.  Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.

Authors:  Ingunn M Stromnes; Carla Fowler; Chanel C Casamina; Christina M Georgopolos; Megan S McAfee; Thomas M Schmitt; Xiaoxia Tan; Tae-Don Kim; Inpyo Choi; Joseph N Blattman; Philip D Greenberg
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

6.  A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness.

Authors:  E D Gordon; S S Sidhu; Z-E Wang; P G Woodruff; S Yuan; M C Solon; S J Conway; X Huang; R M Locksley; J V Fahy
Journal:  Clin Exp Allergy       Date:  2011-08-22       Impact factor: 5.018

7.  STAT3 governs hyporesponsiveness and granzyme B-dependent suppressive capacity in human CD4+ T cells.

Authors:  Klaus G Schmetterer; Alina Neunkirchner; Daniela Wojta-Stremayr; Judith Leitner; Peter Steinberger; Winfried F Pickl
Journal:  FASEB J       Date:  2014-11-14       Impact factor: 5.191

8.  Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens.

Authors:  Cezmi A Akdis; Mübeccel Akdis
Journal:  World Allergy Organ J       Date:  2015-05-14       Impact factor: 4.084

Review 9.  Mechanisms of immune tolerance to allergens in children.

Authors:  Umut C Kucuksezer; Cevdet Ozdemir; Mübeccel Akdis; Cezmi A Akdis
Journal:  Korean J Pediatr       Date:  2013-12-20

10.  Regulation of adaptive immunity; the role of interleukin-10.

Authors:  T H Sky Ng; Graham J Britton; Elaine V Hill; Johan Verhagen; Bronwen R Burton; David C Wraith
Journal:  Front Immunol       Date:  2013-05-31       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.